Shares News

Viking Therapeutics stock forecast: VK2735 Phase III progress
Viking Therapeutics is developing VK2735 for obesity, with two Phase III VANQUISH trials fully enrolled and maintenance-dosing results due this quarter. Explore third-party VKTX price targets and technical analysis. Past performance is not a reliable indicator of future results.
10:39, 23 September 2026

Zalando stock forecast: Board member share sale
Zalando is a German online fashion retailer listed in Frankfurt. On 9 September 2026, board member Astrid Arndt sold 1,735 shares to cover taxes and related costs. Explore third-party ZAL price targets and technical analysis. Past performance is not a reliable indicator of future results.
09:57, 23 September 2026

The Fed hiked and signalled more. Four reasons the Nasdaq rebounded anyway
Why did the Nasdaq 100 rebound after the Fed raised interest rates? Explore how resilient earnings, committed AI spending and easing bond yields supported the recovery and what the US 100 chart suggests could come next.
05:20, 18 September 2026

Volkswagen forecast 2025-2030: Third-party price target
Volkswagen’s supervisory board approved Future Plan 2030 on 3 September, including further job cuts and measures that could cost about €16bn. Explore third-party VOW price targets and technical analysis. Past performance is not a reliable indicator of future results.
19:46, 23 December 2021